Literature DB >> 21543760

Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

Stéphanie Rigaud1, Eduardo Lopez-Granados, Sophie Sibéril, Geoffrey Gloire, Nathalie Lambert, Christelle Lenoir, Cindy Synaeve, Maria Stacey, Lars Fugger, Jean-Louis Stephan, Alain Fischer, Capucine Picard, Anne Durandy, Helen Chapel, Sylvain Latour.   

Abstract

The present study focuses on a large family with an X-linked immunodeficiency in which there are variable clinical and laboratory phenotypes, including recurrent viral and bacterial infections, hypogammaglobulinemia, Epstein-Barr virus-driven lymphoproliferation, splenomegaly, colitis, and liver disease. Molecular and genetic analyses revealed that affected males were carriers of a hypomorphic hemizygous mutation in XIAP (XIAP(G466X)) that cosegregated with a rare polymorphism in CD40LG (CD40 ligand(G219R)). These genes are involved in the X-linked lymphoproliferative syndrome 2 and the X-linked hyper-IgM syndrome, respectively. Single expression of XIAP(G466X) or CD40L(G219R) had no or minimal effect in vivo, although in vitro, they lead to altered functional activities of their gene products, which suggests that the combination of XIAP and CD40LG mutations contributed to the expression of clinical manifestations observed in affected individuals. Our report of a primary X-linked immunodeficiency of oligogenic origin emphasizes that primary immunodeficiencies are not caused by a single defective gene, which leads to restricted manifestations, but are likely to be the result of an interplay between several genetic determinants, which leads to more variable clinical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543760     DOI: 10.1182/blood-2011-01-328849

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia.

Authors:  Barun Kumar Lal; Adrian Stanley
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.

Authors:  Tábata Takahashi França; Lucila Akune Barreiros; Ranieri Coelho Salgado; Sarah Maria da Silva Napoleão; Lillian Nunes Gomes; Janáira Fernandes Severo Ferreira; Carolina Prando; Cristina Worm Weber; Regina Sumiko Watanabe Di Gesu; Cecilia Montenegro; Carolina Sanchez Aranda; Gisele Kuntze; Aidé Tamara Staines-Boone; Edna Venegas-Montoya; Juan Carlos Aldave Becerra; Liliana Bezrodnik; Daniela Di Giovanni; Ileana Moreira; Gisela Analia Seminario; Andrea Cecilia Gómez Raccio; Mayra de Barros Dorna; Nelson Augusto Rosário-Filho; Herberto Jose Chong-Neto; Elisa de Carvalho; Milena Baptistella Grotta; Julio Cesar Orellana; Miguel Garcia Dominguez; Oscar Porras; Laura Sasia; Karina Salvucci; Emilio Garip; Luiz Fernando Bacarini Leite; Wilma Carvalho Neves Forte; Fernanda Pinto-Mariz; Ekaterini Goudouris; María Enriqueta Nuñez Nuñez; Magdalena Schelotto; Laura Berrón Ruiz; Diana Inés Liberatore; Hans D Ochs; Otavio Cabral-Marques; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2022-01-04       Impact factor: 8.317

Review 4.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

5.  High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.

Authors:  Marie Lind-Holst; Ulla Birgitte Hartling; Anne Estmann Christensen
Journal:  BMJ Case Rep       Date:  2019-08-04

6.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.

Authors:  Qi Li; Cheng Hiang Lee; Lauren A Peters; Lucas A Mastropaolo; Cornelia Thoeni; Abdul Elkadri; Tobias Schwerd; Jun Zhu; Bin Zhang; Yongzhong Zhao; Ke Hao; Antonio Dinarzo; Gabriel Hoffman; Brian A Kidd; Ryan Murchie; Ziad Al Adham; Conghui Guo; Daniel Kotlarz; Ernest Cutz; Thomas D Walters; Dror S Shouval; Mark Curran; Radu Dobrin; Carrie Brodmerkel; Scott B Snapper; Christoph Klein; John H Brumell; Mingjing Hu; Ralph Nanan; Brigitte Snanter-Nanan; Melanie Wong; Francoise Le Deist; Elie Haddad; Chaim M Roifman; Colette Deslandres; Anne M Griffiths; Kevin J Gaskin; Holm H Uhlig; Eric E Schadt; Aleixo M Muise
Journal:  Gastroenterology       Date:  2016-02-04       Impact factor: 22.682

7.  XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC.

Authors:  Li He; Tejasav S Sehrawat; Vikas K Verma; Amaia Navarro-Corcuera; Guneet Sidhu; Amy Mauer; Xin Luo; Tomohiro Katsumi; Jingbiao Chen; Soni Shah; Juan Pablo Arab; Sheng Cao; Hamid Kashkar; Gregory J Gores; Harmeet Malhi; Vijay H Shah
Journal:  Front Physiol       Date:  2021-05-07       Impact factor: 4.755

8.  Bilateral lung transplantation in a patient with humoral immune deficiency: a case report with review of the literature.

Authors:  Jocelyn R Farmer; Caroline L Sokol; Francisco A Bonilla; Mandakolathur R Murali; Richard L Kradin; Todd L Astor; Jolan E Walter
Journal:  Case Reports Immunol       Date:  2014-10-15

9.  A mutation in X-linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein-Barr virus-specific T cells.

Authors:  E Lopez-Granados; M Stacey; A-K Kienzler; S Sierro; C B Willberg; C P Fox; S Rigaud; H M Long; A D Hislop; A B Rickinson; S Patel; S Latour; P Klenerman; H Chapel
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 10.  Evolution of Our Understanding of XIAP Deficiency.

Authors:  Anne C A Mudde; Claire Booth; Rebecca A Marsh
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.